文献速递临床试验与 GCP流行病学与生物统计

通过非专业提供者和远程医疗扩大孕产妇心理健康服务可及性(SUMMIT):非劣效随机对照试验研究方案

Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trial.
PubMed 文献 · Trials · 2021-03-05

SUMMIT是一项实用性非劣效随机对照试验,旨在比较专业与非专业提供者、远程医疗与面对面两种模式下简短行为激活(BA)治疗围产期抑郁和焦虑症状的效果。计划纳入EPDS≥10的孕产妇1368例,随机分入四组,主要结局为随机化后3个月EPDS评分。研究预期为非专业提供者和远程医疗的非劣效性提供证据,若成立可大幅提高治疗可及性。

要点

  • 非专业提供者(护士、助产士)经培训并接受BA专家督导,可望扩大围产期抑郁焦虑治疗可及性。
  • 远程医疗与面对面两种交付模式的效果对比是本研究核心问题之一。
  • 主要结局为随机化后3个月EPDS评分,采用按方案和意向性分析。

核心结论

  • SUMMIT试验预期生成非专业提供者对比专业提供者、远程医疗对比面对面交付BA治疗非劣效性的证据。

研究设计与样本

  • 实用性非劣效随机对照试验,计划纳入EPDS≥10的孕产妇N=1368,随机分入四组(远程专业、远程非专业、面对面专业、面对面非专业),按妊娠状态和研究中心分层。

主要发现

  • 主要结局为随机化后3个月参与者报告的抑郁症状(EPDS)。
  • 次要结局包括随机化后3、6、12个月的焦虑和创伤症状、感知社会支持、激活水平和生活质量,以及6、12个月抑郁症状。
  • 主要分析为按方案和意向性分析。
  • 研究在COVID-19疫情期间继续,临时暂停面对面组并持续随机化至远程医疗组。

关键数值与推荐

  • 纳入标准:妊娠或产后女性,EPDS评分≥10。
  • 专业提供者定义为具有≥5年治疗经验的心理学家、精神科医生和社会工作者;非专业提供者为无正式心理健康培训的护士和助产士,治疗期间由BA专家督导。

临床怎么用

  • 若非劣效性成立,可支持任务共享模式,由非专业提供者通过远程医疗交付BA治疗以扩大围产期抑郁焦虑治疗可及性。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression and anxiety impact up to 1 in 5 pregnant and postpartum women worldwide. Yet, as few as 20% of these women are treated with frontline interventions such as evidence-based psychological treatments. Major barriers to uptake are the limited number of specialized mental health treatment providers in most settings, and problems with accessing in-person care, such as childcare or transportation. Task sharing of treatment to non-specialist providers with delivery on telemedicine platforms could address such barriers. However, the equivalence of these strategies to specialist and in-person models remains unproven. METHODS: This study protocol outlines the Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) randomized trial. SUMMIT is a pragmatic, non-inferiority test of the comparable effectiveness of two types of providers (specialist vs. non-specialist) and delivery modes (telemedicine vs. in-person) of a brief, behavioral activation (BA) treatment for perinatal depressive and anxiety symptoms. Specialists (psychologists, psychiatrists, and social workers with ≥ 5 years of therapy experience) and non-specialists (nurses and midwives with no formal training in mental health care) were trained in the BA protocol, with the latter supervised by a BA expert during treatment delivery. Consenting pregnant and postpartum women with Edinburgh Postnatal Depression Scale (EPDS) score of ≥ 10 (N = 1368) will be randomized to one of four arms (telemedicine specialist, telemedicine non-specialist, in-person specialist, in-person non-specialist), stratified by pregnancy status (antenatal/postnatal) and study site. The primary outcome is participant-reported depressive symptoms (EPDS) at 3 months post-randomization. Secondary outcomes are maternal symptoms of anxiety and trauma symptoms, perceived social support, activation levels and quality of life at 3-, 6-, and 12-month post-randomization, and depressive symptoms at 6- and 12-month post-randomization. Primary analyses are per-protocol and intent-to-treat. The study has successfully continued despite the COVID-19 pandemic, with needed adaptations, including temporary suspension of the in-person arms and ongoing randomization to telemedicine arms. DISCUSSION: The SUMMIT trial is expected to generate evidence on the non-inferiority of BA delivered by a non-specialist provider compared to specialist and telemedicine compared to in-person. If confirmed, results could pave the way to a dramatic increase in access to treatment for perinatal depression and anxiety. TRIAL REGISTRATION: ClinicalTrials.gov NCT04153864 . Registered on November 6, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Singla DR, Meltzer-Brody SE, Silver RK, et al. Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trial. Trials. 2021. PMID: 33673867. doi:10.1186/s13063-021-05075-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。